SUMMARY The phenomenon of increased spontaneous incorporation of into peripheral blood mononuclear cells in rheumatoid arthritis (RA) has been investigated. The activity was found to be short lived and affected less than 1% of cells. Using a Percoll density gradient we identified two populations of active cells. RA patients with active synovitis and increased 3H-TdR incorporation in the low density population of cells have higher overall 3H-TdR incorporation than normal controls and patients with inactive RA. The low density cell population is enriched for Ia, cells. The data are cnsistent with raised spontaneous 3H-TdR incorporation being due to an in-vivo cell mediated immune response.
The nature of the events which initiate, and then allow, the persistence of inflammation and immunological abnormalities in rheumatoid arthritis (RA) is poorly understood. 'Atypical' lymphocytes have been described in RA' but the questions of the lineage of these cells and whether they are the same as those described in infectious mononucleosis and renal transplantation have not been answered conclusively. [2] [3] [4] [5] [6] [7] Developments in monoclonal antibody technology and methods for studying the interactions between lymphocyte subpopulations have led to a renewed interest in in-vivo activated lymphocytes in a variety of autoimmune diseases, including RA.8-0.
We have approached this question in two ways. We have used the phenomenon of spontaneous incorporation of 3H-TdR into mononuclear cells as the criterion of activation, and have asked firstly whether the spontaneous activity seen in peripheral blood mononuclear cells from RA patients resembles the proliferative phase of a mitogen or alloantigen stimulated lymphocyte reaction, and secondly whether the activity relates to disease status. In this first report we describe the occurrence Accepted for publication 16 April 1984. Correspondence to Dr Karin Froebel, University Department of Medicine, Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER.
of spontaneous activity with time in peripheral blood mononuclear cells of RA patients and its relation to other disease parameters. We also present the results of preliminary investigations into the nature of the activated cell.
Materials and methods
Subjects. The patients selected had active RA'1 but were not receiving penicillamine-like drugs or steroids; they had not had recent surgery, a blood transfusion, or infection. Controls were healthy members of staff, age and sex matched with the patients, and tested concurrently with the patients. Blood samples were always taken between 8 and 10 am to minimise any possible diurnal effects. In the longitudinal study, samples from 12 patients and 10 controls were tested serially over a period of four to eight weeks each, with intervals of two to seven days between samples. For the density gradient experiments samples from 23 RA patients, 16 of whom were receiving either oral or injectable gold therapy, were tested. The patients were assessed clinically at the time of blood sampling by means of a multiparameter assessment devised by Mallya and Mace. ' (Fig. 3) The Ia-positive cells may be activated T cells27 the result of a cellular immune response. However, the finding that Ia-positive lymphocytes are able to present antigen28 2 raises the intriguing possibility that these cells might be involved in perpetuating the immune response in chronic RA patients by providing an antigenic stimulus.
In conclusion, therefore, we have shown that a proportion of RA patients have increased levels of spontaneous 3H-TdR incorporation compared with normal controls. The activity is associated with two populations of cells which can be separated by density. More active disease appears to be associated with increased 3H-TdR incorporation in a low density cell population which is characterised by an enrichment of Ia-positive cells. Further work on the morphology and the function of activated cells in both populations is required to clarify the type of immunological activity that is taking place.
